These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12445037)

  • 1. Prevalence of factitious hypoglycaemia associated with sulphonylurea drugs in France in the year 2000.
    Trenque T; Frances C; Millart H; Hoizey G; Germain ML
    Br J Clin Pharmacol; 2002 Nov; 54(5):548. PubMed ID: 12445037
    [No Abstract]   [Full Text] [Related]  

  • 2. Factitious hypoglycaemia.
    Yates C; Neoh S; Konpa A; Fullinfaw R; Colman P
    Intern Med J; 2009 Dec; 39(12):e15-7. PubMed ID: 20233233
    [No Abstract]   [Full Text] [Related]  

  • 3. Sulfonylurea-induced factitious hypoglycemia in a nondiabetic nurse.
    Walfish PG; Kashyap RP; Greenstein S
    Can Med Assoc J; 1975 Jan; 112(1):71-2. PubMed ID: 803250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia.
    Graudins A; Linden CH; Ferm RP
    Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-acting sulfonylureas -- long-acting hypoglycaemia.
    Veitch PC; Clifton-Bligh RJ
    Med J Aust; 2004 Jan; 180(2):84-5. PubMed ID: 14723592
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sulfonylurea-induced hypoglycemia. An iatrogenic and potentially fatal condition].
    Carlsen SM
    Tidsskr Nor Laegeforen; 1997 Sep; 117(21):3079-82. PubMed ID: 9381441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between CYP2C9 slow metabolizer genotypes and severe hypoglycaemia on medication with sulphonylurea hypoglycaemic agents.
    Holstein A; Plaschke A; Ptak M; Egberts EH; El-Din J; Brockmöller J; Kirchheiner J
    Br J Clin Pharmacol; 2005 Jul; 60(1):103-6. PubMed ID: 15963101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using pharmacoepidemiological findings to guide clinical practice: sulfonylureas and hypoglycemia in older adults.
    Gurwitz JH
    J Am Geriatr Soc; 1996 Jul; 44(7):871-2. PubMed ID: 8675941
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P; Mavros P; Krishnarajah G; Lyu R; Yin D
    Diabetes Obes Metab; 2008 Jun; 10 Suppl 1():16-24. PubMed ID: 18435670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hardly any hypoglycemias, constant weight--and still cost effective].
    MMW Fortschr Med; 2005 Nov; 147(47):72-3. PubMed ID: 16370200
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulphonylurea-induced hypoglycaemia in institutionalized elderly in Hong Kong.
    So WY; Chan JC; Yeung VT; Chow CC; Ko GT; Li JK; Cockram CS
    Diabet Med; 2002 Nov; 19(11):966-8. PubMed ID: 12421437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Differences in insulin secretion facilitate the differential diagnosis of insulinoma and factitious hypoglycaemia].
    Meier JJ; Hücking K; Grüneklee D; Schmiegel W; Nauck MA
    Dtsch Med Wochenschr; 2002 Feb; 127(8):375-8. PubMed ID: 11859446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factitious hypoglycaemia documented by a modified assay for the measurement of plasma sulphonylurea.
    Sener A; Gillet C; Verhelst J; DeBoeck K; Mahler C; Malaisse WJ
    Diabet Med; 1995 May; 12(5):433-5. PubMed ID: 7648808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide treatment for sulfonylurea-induced hypoglycaemia.
    Crawford BA; Perera C
    Med J Aust; 2004 May; 180(10):540-1; author reply 541. PubMed ID: 15139835
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulphonylurea-induced hypoglycaemia in type 2 diabetes mellitus: a review.
    Burge MR; Sood V; Sobhy TA; Rassam AG; Schade DS
    Diabetes Obes Metab; 1999 Jul; 1(4):199-206. PubMed ID: 11228754
    [No Abstract]   [Full Text] [Related]  

  • 16. [Non usual cases of hypoglycaemia--hypoglycaemia factitia].
    Mokán M; Galajda P; Mokán M
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S45-9. PubMed ID: 27124972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin with sulfonylureas and hypoglycemic events: consider dose, length of treatment, and all sulfonylureas.
    Bosco-Lévy P; Salvo F
    BMJ; 2016 Aug; 354():i4328. PubMed ID: 27495245
    [No Abstract]   [Full Text] [Related]  

  • 18. Authors' reply to Bosco-Lévy and Salvo.
    Romley JA; Gong C; Jena AB; Goldman DP; Williams B; Peters A
    BMJ; 2016 Aug; 354():i4330. PubMed ID: 27496026
    [No Abstract]   [Full Text] [Related]  

  • 19. [Factitious hypoglycemia caused by taking a sulfonylurea drug].
    Siegel EG; Mayer G; Nauck M; Creutzfeldt W
    Dtsch Med Wochenschr; 1987 Oct; 112(41):1575-9. PubMed ID: 3117513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
    Confederat L; Constantin S; Lupaşcu F; Pânzariu A; Hăncianu M; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):579-84. PubMed ID: 26204670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.